Laboratory of Yohan Bossé 

"Translating scientific discoveries into marketable applications or products to improve diagnostic and treatment of patients afflicted with heart and lung diseases."

 

 

Identify a prognostic gene signature for stage I lung adenocarcinoma

 

We discovered and validated a gene expression signature in non-tumor lung tissues that identified patients with poor prognosis following lung resection for stage I pulmonary adenocarcinoma. We also developed a convenient qPCR assay that we aim to implement in clinical settings in order to guide adjuvant therapy beyond clinicopathologic staging. An international patent describing this technology was published in April 2014 (please see patent WO/2014/047723 at www.wipo.int/pctdb).